arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Orchestra BioMed Holdings, Inc.

OBIO Health Care Medicinal Chemicals and Botanical Products
$5.47
▼ -6.0% Today
as of Oct 22, 16:51 ET
Last 30 days -7.29% Sep 14 → Oct 22
$5.38 $5.64 $5.90 $6.16 $6.42 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$5.72
High
$5.79
Low
$5.43
Volume
$390,873
Avg Vol
$279,607
Mkt Cap
$382M
P/E (TTM)
—
Beta
—
52w High
$6.50
52w Low
$3.46
Div Yield
—
Shares Out
$60M

Recent Press Releases & News last 60 days · 11 items

Oct 22 · 12:30 PR GlobeNewswire
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
Oct 20 · 18:35 Investing.com
OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports
Oct 1 · 12:00 PR GlobeNewswire
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
▸ Show all 11 press releases & news Free account →

OBIO earnings at a glance

The options market is pricing a move of about ±26.5% after the report, a range of roughly $4.02 to $6.92 from today's $5.47. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.9% on average; after the most recent report on May 12, 2026 it moved +3.8%. That means options currently expect more movement than OBIO has typically delivered. OBIO beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 224%. The share price of $5.47 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.46
$6.50
66% of range
Avg surprise (last 4)
+1.9%
Avg reaction (last 2)
+1.9%
50% positive
Latest IV / EM
224%
EM ±26.5% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.51$-0.47$-0.42$-0.38$-0.33 Actual $-0.40Actual $-0.35Actual $-0.38Actual $-0.38Actual $-0.45Actual $-0.41Actual $-0.49Est $-0.46Actual $-0.50Est $-0.51Actual $-0.40Est $-0.38Actual $-0.33Est $-0.40Actual $-0.38 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-24M$-18M$-11M$-5M$1M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.38 — — — — financials
Tue May 12, 2026Mar/2026 $-0.33 $-0.40 +17.5% +32.6% +3.8% earnings
Mon Nov 10, 2025Sep/2025 $-0.40 $-0.38 -5.3% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.50 $-0.51 +2.0% — — earnings
Mon May 12, 2025Mar/2025 $-0.49 $-0.46 -6.5% — 0.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.41 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.45 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.38 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.35 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.40 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$88,000$110,000—$861,000$836,000$868,000—$987,000
Cost of revenue$25,000$32,000—$49,000$46,000$44,000—$68,000
Gross profit————————
Operating income$-22M$-22M—$-20M$-19M$-19M—$-16M
Net income$-24M$-21M—$-21M$-19M$-19M—$-15M
EPS (diluted)$-0.38$-0.33—$-0.40$-0.50$-0.49—$-0.41

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$20M$28M$35M$42M$19M$18M$22M$26M
Inventory$250,000$277,000$310,000$365,000$185,000$135,000$173,000$234,000
Total current assets$111M$96M$108M$98M$36M$52M$69M$69M
Total assets$116M$101M$115M$105M$43M$59M$76M$75M
Long-term debt—$15M—$15M$15M$15M——
Total liabilities$86M$50M$51M$61M$43M$42M$43M$29M
Total equity$19M$41M$54M$44M$295,000$17M—$46M

Implied volatility — last 90 days

88%501%913%1325%1737% Jun 07 — IV 398% · EM ±55.1%Jun 08 — IV 412% · EM ±54.4%Jun 09 — IV 446% · EM ±55.8%Jun 11 — IV 434% · EM ±47.9%Jun 12 — IV 465% · EM ±47.6%Jun 15 — IV 714% · EM ±51.6%Jun 16 — IV 989% · EM ±58.4%Jun 17 — IV 1454% · EM ±60.7%Jun 19 — IV 255% · EM ±56.4%Jun 22 — IV 229% · EM ±47.8%Jun 23 — IV 254% · EM ±52.0%Jun 24 — IV 270% · EM ±54.0%Jun 25 — IV 288% · EM ±56.4%Jun 26 — IV 283% · EM ±54.2%Jun 29 — IV 210% · EM ±37.2%Jul 01 — IV 209% · EM ±34.9%Jul 02 — IV 217% · EM ±35.1%Jul 03 — IV 229% · EM ±35.8%Jul 07 — IV 956% · EM ±126.3%Jul 08 — IV 478% · EM ±59.9%Jul 09 — IV 1112% · EM ±131.4%Jul 13 — IV 925% · EM ±77.2%Jul 14 — IV 1030% · EM ±74.5%Jul 15 — IV 1229% · EM ±72.6%Jul 16 — IV 1738% · EM ±72.6%Jul 20 — IV 268% · EM ±63.3%Jul 21 — IV 379% · EM ±88.1%Jul 22 — IV 337% · EM ±77.1%Jul 23 — IV 366% · EM ±82.4%Jul 24 — IV 321% · EM ±70.9%Jul 27 — IV 345% · EM ±72.0%Jul 28 — IV 317% · EM ±64.8%Jul 29 — IV 217% · EM ±43.4%Jul 31 — IV 295% · EM ±56.5%Aug 03 — IV 301% · EM ±53.4%Aug 04 — IV 224% · EM ±38.6%Aug 05 — IV 248% · EM ±41.5%Aug 06 — IV 305% · EM ±49.4%Aug 07 — IV 226% · EM ±35.4%Aug 10 — IV 266% · EM ±36.9%Aug 11 — IV 215% · EM ±28.4%Aug 12 — IV 406% · EM ±50.9%Aug 13 — IV 219% · EM ±25.8%Aug 18 — IV 281% · EM ±20.4%Aug 19 — IV 297% · EM ±17.6%Aug 24 — IV 128% · EM ±26.7%Aug 26 — IV 133% · EM ±26.6%Sep 01 — IV 89% · EM ±15.3%Sep 08 — IV 188% · EM ±24.9%Sep 09 — IV 168% · EM ±21.1%Sep 10 — IV 408% · EM ±48.2%Sep 11 — IV 333% · EM ±36.8%Sep 14 — IV 436% · EM ±36.4%Sep 15 — IV 504% · EM ±36.4%Sep 16 — IV 634% · EM ±37.4%Sep 17 — IV 725% · EM ±30.3%Sep 21 — IV 195% · EM ±40.8%Sep 23 — IV 198% · EM ±39.6%Sep 25 — IV 206% · EM ±39.5%Sep 28 — IV 196% · EM ±34.8%Sep 29 — IV 210% · EM ±36.2%Sep 30 — IV 231% · EM ±38.6%Oct 01 — IV 234% · EM ±37.8%Oct 06 — IV 259% · EM ±34.2%Oct 07 — IV 212% · EM ±26.5%Oct 08 — IV 224% · EM ±26.5%

Sector peers

SNDL
SNDL Inc.
$308M $1.29+0.8%
USNA
USANA Health Sciences, Inc.
$271M $14.52-1.4%
NAGE
Niagen Bioscience, Inc.
$215M $2.52+0.4%
UPXI
Upexi, Inc.
$102M $0.80-9.1%
FTLF
FitLife Brands, Inc.
$87M $8.22+1.2%
ISPR
Ispire Technology Inc.
$81M $1.360.0%

OBIO earnings FAQ

What is OBIO's expected move for earnings?

Options currently price a move of about ±26.5%, or $1.45 per share either way from $5.47.

How does OBIO stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.9%, up 1 times and down 1 times.

What is OBIO's implied volatility?

OBIO's at-the-money implied volatility is about 224% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in